Meta-analysis of the control arms of 10 RCTs (N=1366) in high-risk IgA nephropathy: maximally tolerated RAAS inhibitors alone were associated with a mean annual eGFR decline of −4.5 ml/min/1.73 m² (95% CI −5.3 to −3.8), a rate that may not limit ESKD risk.
Meta-analysisn = 1,366
Rastogi et al. The Impact of Renin-Angiotensin-Aldosterone System Inhibitors in IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials